Biological
Autologous Tumor Cell Vaccine clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2000
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2000 (1)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2006 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 5
Dartmouth-Hitchcock Medical Center (1) · Hoag Memorial Hospital Presbyterian (1) · University of Nebraska (1) · Dana-Farber Cancer Institute (1) · University of Medicine and Dentistry of New Jersey (1)
Often tested with
Tested in the same studies.
Aldesleukin (1) · Therapeutic Autologous Dendritic Cells (1) · Keyhole limpet hemocyanin (1) · Sargramostim (1)
Studies
Open first, then newest update. How each study uses Autologous Tumor Cell Vaccine is read from its arms, and is right about nine times in ten.
Testing it · 5
- Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's LymphomaTerminatedPhase 2University of NebraskaNCT00006478Written as autologous tumor cell vaccine
- DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCCCompletedPhase 2Dartmouth-Hitchcock Medical CenterNCT00085436Written as autologous tumor cell vaccine
- Vaccine Therapy in Treating Patients With Acute Lymphoblastic LeukemiaTerminatedEarly Phase 1Dana-Farber Cancer InstituteNCT00020670Written as CD 40
- Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic MelanomaCompletedPhase 2Hoag Memorial Hospital PresbyterianNCT00436930Written as autologous tumor cell vaccine
- Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the LarynxStatus unknownPhase 2University of Medicine and Dentistry of New JerseyNCT00002454Written as autologous tumor cell vaccine